Managed Care Calendar
- AAPM 2010 Clinical Meeting
Poll
Privacy Policy/Copyright
Copyright
© 2010 by HMP Communications, LLC All rights reserved. Opinions expressed by authors are their own and not necessarily those of HMP Communications, LLC, the editorial staff, or any member of the editorial advisory board. Reprints of articles are available. Contact HMP Communications, LLC for information.
Privacy
HMP Communications pledges always to respect the privacy and anonymity of its users, including survey participants. The information (the names, email addresses or any other contact information, personal or medical data) provided to us by our visitors in their registrations and communications with us is securely stored and not shared with any third party. HMP is committed to working with the Internet community in cultivating and maintaining trust between all its members.
REQUIP XL is an oral dopamine agonist medication for Parkinson’s disease and had demonstrated significant improvement in the symptoms of Parkinson’s disease.
The Role of Immune Function in the Changing Landscape of RRMS Therapies
Gastroesophageal reflux disease (GERD) is an important
managed care health concern because it is one of the most common gastrointestinal (GI) disorders in the United
States. GERD affects nearly 18.6 million Americans, according to a national healthcare database analysis.
Parkinson’s disease (PD) is a progressive
and disabling neurologic disorder. The disease is the most prevalent type of parkinsonism, a clinical syndrome caused by lesions in the basal ganglia, predominantly in the substantia nigra, which produces deficits in motor behavior.
